Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 7526 record(s)

Req # A-2019-001340

Adverse Reaction Report (AER). Report number: E2B_02620893.

Organization: Health Canada

7 page(s)
February 2020

Req # A-2019-001342

Adverse Reaction Report (AER). Report number: E2B_02670649.

Organization: Health Canada

10 page(s)
February 2020

Req # A-2019-001348

Adverse Reaction Report (AER) for VEDOLIZUMAB. Report numbers: 725289, 728451, E2B_02445741, E2B_02450172, E2B_02459903, E2B_02476745, E2B_02477366, E2B_02482124, E2B_02545200, E2B_02555422, E2B_02555477, E2B_02577912, E2B_02578003, E2B_02597273, E2B_02653348, E2B_02661299, E2B_02666942, E2B_02670702.

Organization: Health Canada

275 page(s)
February 2020

Req # A-2019-001349

Adverse Reaction Report (AER) for NINLARO. Report numbers: E2B_02475335, E2B_02475402, E2B_02520346, E2B_02532303, E2B_02534392, E2B_02534423, E2B_02540687, E2B_02570458.

Organization: Health Canada

112 page(s)
February 2020

Req # A-2019-001409

Adverse Reaction Report (AER). Report number: 000727851.

Organization: Health Canada

3 page(s)
February 2020

Req # A-2019-001427

Adverse Reaction Report (AER) for Amitiza. Report number: 000728066.

Organization: Health Canada

3 page(s)
February 2020

Req # A-2019-001448

Adverse Reaction Report (AER). Report numbers: E2B_02689797, E2B_02690177.

Organization: Health Canada

24 page(s)
February 2020

Req # A-2019-001449

Adverse Reaction Report (AER). Report numbers: E2B_02694290, E2B_02695621, E2B_02696543.

Organization: Health Canada

35 page(s)
February 2020

Req # A-2019-001450

Adverse Reaction Report (AER). Report numbers: E2B_02671566, E2B_02671570, E2B_02671571, E2B_02672070.

Organization: Health Canada

66 page(s)
February 2020

Req # A-2019-001478

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-119610-635.

Organization: Health Canada

14 page(s)
February 2020
Date modified: